Linking survival of HER2-positive breast carcinoma patients with surgical invasiveness
Open Access
- 31 May 2006
- journal article
- research article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 42 (8), 1057-1061
- https://doi.org/10.1016/j.ejca.2005.12.021
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Role of HER2 in wound-induced breast carcinoma proliferationThe Lancet, 2003
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic markerEuropean Journal Of Cancer, 2001
- Prognostic significance of biologic markers in node-negative breast cancer patients: a prospective studyBreast Cancer Research and Treatment, 2000
- Molecular portraits of human breast tumoursNature, 2000
- Clinical Progression of Breast Cancer Malignant Behavior: What to Expect and When to Expect itJournal of Clinical Oncology, 2000
- HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.Journal of Clinical Oncology, 1997
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Comparing Radical Mastectomy with Quadrantectomy, Axillary Dissection, and Radiotherapy in Patients with Small Cancers of the BreastNew England Journal of Medicine, 1981